secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zentalis Pharmaceuticals, Inc. (ZNTL)
CIK:        0001725160
Form:       8-K/A
Filed at:   2024-12-19T23:59:59+00:00
Accession:  0001725160-24-000193
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Zentalis appoints Scott Myers to Compensation Committee; annual retainer $7,500
-------------------------------------------------------------------------------

- Scott Myers appointed to Compensation Committee effective December 17, 2024.
- Annual retainer of $7,500 for committee service under Non-Employee Director Compensation Program.
- This amendment to the Nov 13, 2024 8-K adds the committee role and related compensation.
- No other changes to the original 8-K filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725160/000172516024000193/0001725160-24-000193-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725160/000172516024000193/zntl-20241217.htm
  HTML page:      https://secwatch.observer/filing/0001725160-24-000193

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer